¹û¶³Ö±²¥ÊÓƵ

WOMAN-2 trial collaborators. Electronic address: w,; WOMAN-2 trial collaborators,;

SHAKUR-STILL, H; ROBERTS, I; Grassin-Delyle, S; Chaudhri, R; GEER, A; ARRIBAS, M; Lamy, E; MANSUKHANI, R; Lubeya, MK; Javaid, K; Kayani, A; Israr, N; Mazhar, SB; Urien, S; Bouazza, N; Foissac, F; Prowse, D; Carrington, L; Barrow, C; ONANDIA, JG; BALOGUN, E;

ARRIBAS, M; ROBERTS, I; Chaudhri, R; GEER, A; Prowse, D; Lubeya, MK; Kayani, A; Javaid, K; Grassin-Delyle, S; SHAKUR-STILL, H;

ROBERTS, I; SHAKUR-STILL, H; Aeron-Thomas, A; BEAUMONT, D; Belli, A; BRENNER, A; Cargill, M; Chaudhri, R; Douglas, N; Frimley, L; Gilliam, C; GEER, A; JAMAL, Z; Jooma, R; MANSUKHANI, R; MINERS, A; Pott, J; Prowse, D; Shokunbi, T; WILLIAMS, J;

BRENNER, A; Belli, A; Chaudhri, R; Coats, T; Frimley, L; Jamaluddin, SF; Jooma, R; MANSUKHANI, R; Sandercock, P; SHAKUR-STILL, H; Shokunbi, T; ROBERTS, I; CRASH-3 trial collaborators,;

HALT-IT Trial Collaborators,;

GEER, A; Prowse, D;

AGERON, F-X; Gayet-Ageron, A; Ker, K; Coats, TJ; SHAKUR-STILL, H; Roberts, I; Antifibrinolytics Trials Collaboration,;

CRASH-3 trial collaborators,;

Gayet-Ageron, A; PRIETO-MERINO, D; Ker, K; SHAKUR, H; AGERON, F-X; ROBERTS, I; Antifibrinolytic Trials Collaboration,;